Keyphrases
Left Ventricular Assist Device
71%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
44%
Left Ventricular Assist Device Implantation
42%
Single Center
39%
Lung Transplantation
36%
Out-of-hospital Cardiac Arrest
32%
Gold Nanoparticles
28%
Minnesota
24%
Synthetic Approaches
23%
Confidence Interval
23%
Controlled Functionalization
21%
Long-term Survival
21%
Solid-phase Synthesis
21%
Transfusion Protocol
21%
Artificial Placenta
21%
Heart Transplantation
20%
Lung
19%
Solid Phase
19%
Cryoprecipitate
18%
Extubation
18%
Position Exchange
18%
Exchange Reaction
18%
Transplantation
16%
End-stage Heart Failure
16%
Peri-procedural
16%
Extracorporeal Cardiopulmonary Resuscitation
15%
Blood Product Transfusion
15%
Human Heart
14%
Transplant Experiment
14%
Donor Heart
14%
HeartMate 3
13%
Left Ventricular Assist Device Support
13%
Nanoparticles
13%
Platelets
13%
Surgical Technique
13%
Cannulation
13%
Acute Decompensated Heart Failure
12%
Transfusion
12%
Ischemic Cardiomyopathy
12%
Risk Factors
11%
Quality of Life
10%
Ventricular Septal Defect
10%
Cardiothoracic Transplantation
10%
Patient Survival
10%
Membrane Oxygenation
10%
Device Placement
10%
Persistent Problems
10%
Visible Heart
10%
INTERMACS
10%
Transplant Outcomes
10%
Medicine and Dentistry
Left Ventricular Assist Device
100%
Lung Transplantation
43%
Extracorporeal Membrane Oxygenation
40%
Extracorporeal
33%
Lung
33%
Heart Transplantation
33%
Out of Hospital Cardiac Arrest
32%
Congestive Heart Failure
30%
Resuscitation
27%
Long Term Survival
25%
Placenta
21%
Heart Right Ventricle Failure
21%
Observational Study
21%
Blood Product
21%
Valve Replacement
21%
Brain Death
21%
Extubation
16%
Platelet
16%
Ventricular Fibrillation
16%
Clinician
15%
Prematurity
14%
Heart Perfusion
14%
Adverse Event
13%
Cardiogenic Shock
13%
Cannulation
13%
Heart Graft
13%
Hemodynamic
13%
Erythrocyte Transfusion
12%
Ventricular Assist Device
12%
Erythrocyte
12%
Hazard Ratio
11%
Systematic Review
10%
Percutaneous Aortic Valve Replacement
10%
Retrospective Study
10%
Acute Kidney Injury
10%
Tricuspid Valve Replacement
10%
Calciphylaxis
10%
Virus Myocarditis
10%
Anticoagulation
10%
Aortic Valve Replacement
10%
Cardiothoracics
10%
Meta-Analysis
10%
Blood Cell
10%
Mitral Valve Surgery
10%
Ventricular Septal Defect
10%
Right Lung
10%
Randomized Controlled Trial
10%
Coronary Artery Bypass Graft
10%
Mitral Valve Replacement
10%
Medical Student
10%
